Skip Navigation


European Heart Journal Advance Access originally published online on July 10, 2008
European Heart Journal 2008 29(16):1927-1929; doi:10.1093/eurheartj/ehn321
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
29/16/1927    most recent
ehn321v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Agewall, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Agewall, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Acute and stable coronary heart disease: different risk factors

Stefan Agewall*

Department of Medicine, Aker University Hospital and Oslo University, 0514 Oslo, Norway

* Corresponding author. Tel: + 47 228 94655, Fax: + 47 228 94259, Email: stefan.agewall@medisin.uio.no

This editorial refers to ‘Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study’{dagger} by J.-P. Empana et al., on page 1966

Footnotes

The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.

The first 10% of the full text of this article appears below.

Coronary heart disease (CHD) continues to be a worldwide leading cause of death for both men and women. When coronary atherosclerosis progresses, there is deposition of plaque external to the lumen of the artery, thus the plaque may extend eccentrically and outward without compromising the lumen initially. As atherosclerosis worsens the plaque mass may later on bulge into the lumen and may therefore result in a haemodynamic obstruction and angina pectoris symptoms. Typically, angina pectoris develops when an atherosclerotic plaque obstructs at least 70% of the arterial lumen. Thus, stable angina pectoris is a condition in which there is regional myocardial ischaemia caused by inadequate coronary perfusion and is usually induced by increases in myocardial oxygen requirements. Chest pain that . . . [Full Text of this Article]

Same disease or two different diseases?

Classical cardiovascular risk factors

Inflammation
The endothelium
von Willebrand factor
Interpretation of the study


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study
Jean-Philippe Empana, Florence Canoui-Poitrine, Gerald Luc, Irene Juhan-Vague, Pierre Morange, Dominique Arveiler, Jean Ferrieres, Philippe Amouyel, Annie Bingham, Michelle Montaye, Jean-Bernard Ruidavets, Bernadette Haas, Alun Evans, Pierre Ducimetiere, and on behalf of the PRIME Study Group
EHJ 2008 29: 1966-1974. [Abstract] [FREE Full Text]